1	Reactive	reactive	_	_	_	_	_	_	_
2	oxygen	oxygen	_	_	_	_	_	_	_
3	intermediate-dependent	intermediate-dependent	_	_	_	_	_	_	_
4	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
5	activation	activation	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	interleukin-1beta	interleukin-1beta	_	_	_	_	_	_	_
8	requires	require	_	_	_	_	_	_	_
9	5-lipoxygenase	5-lipoxygenase	_	_	_	_	_	_	_
10	or	or	_	_	_	_	_	_	_
11	NADPH	NADPH	_	_	_	_	_	_	_
12	oxidase	oxidase	_	_	_	_	_	_	_
13	activity	activity	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	previously	previously	_	_	_	_	_	_	_
3	reported	report	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	role	role	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	reactive	reactive	_	_	_	_	_	_	_
9	oxygen	oxygen	_	_	_	_	_	_	_
10	intermediates	intermediate	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	ROIs	ROI	_	_	_	_	_	_	_
13	)	)	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
16	activation	activation	_	_	_	_	_	_	_
17	by	by	_	_	_	_	_	_	_
18	proinflammatory	proinflammatory	_	_	_	_	_	_	_
19	cytokines	cytokine	_	_	_	_	_	_	_
20	was	be	_	_	_	_	_	_	_
21	cell	cell	_	_	_	_	_	_	_
22	specific	specific	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	sources	source	_	_	_	_	_	_	_
5	for	for	_	_	_	_	_	_	_
6	ROIs	roi	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	various	various	_	_	_	_	_	_	_
9	cell	cell	_	_	_	_	_	_	_
10	types	type	_	_	_	_	_	_	_
11	are	be	_	_	_	_	_	_	_
12	yet	yet	_	_	_	_	_	_	_
13	to	to	_	_	_	_	_	_	_
14	be	be	_	_	_	_	_	_	_
15	determined	determine	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	might	might	_	_	_	_	_	_	_
18	include	include	_	_	_	_	_	_	_
19	5-lipoxygenase	5-lipoxygenase	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	5-LOX	5-lox	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	NADPH	NADPH	_	_	_	_	_	_	_
25	oxidase	oxidase	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	5-LOX	5-lox	_	_	_	_	_	_	_
2	and	and	_	_	_	_	_	_	_
3	5-LOX	5-lox	_	_	_	_	_	_	_
4	activating	activating	_	_	_	_	_	_	_
5	protein	protein	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	FLAP	FLAP	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	are	be	_	_	_	_	_	_	_
10	coexpressed	coexpresse	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	lymphoid	lymphoid	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	but	but	_	_	_	_	_	_	_
15	not	not	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	monocytic	monocytic	_	_	_	_	_	_	_
18	or	or	_	_	_	_	_	_	_
19	epithelial	epithelial	_	_	_	_	_	_	_
20	cells	cell	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Stimulation	stimulation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	lymphoid	lymphoid	_	_	_	_	_	_	_
4	cells	cell	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	interleukin-1beta	interleukin-1beta	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	IL-1beta	IL-1beta	_	_	_	_	_	_	_
9	)	)	_	_	_	_	_	_	_
10	led	lead	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	ROI	ROI	_	_	_	_	_	_	_
13	production	production	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	NF-kappaB	nf-kappab	_	_	_	_	_	_	_
16	activation	activation	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	which	which	_	_	_	_	_	_	_
19	could	could	_	_	_	_	_	_	_
20	both	both	_	_	_	_	_	_	_
21	be	be	_	_	_	_	_	_	_
22	blocked	block	_	_	_	_	_	_	_
23	by	by	_	_	_	_	_	_	_
24	antioxidants	antioxidant	_	_	_	_	_	_	_
25	or	or	_	_	_	_	_	_	_
26	FLAP	FLAP	_	_	_	_	_	_	_
27	inhibitors	inhibitor	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	confirming	confirm	_	_	_	_	_	_	_
30	that	that	_	_	_	_	_	_	_
31	5-LOX	5-lox	_	_	_	_	_	_	_
32	was	be	_	_	_	_	_	_	_
33	the	the	_	_	_	_	_	_	_
34	source	source	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	ROIs	ROI	_	_	_	_	_	_	_
37	and	and	_	_	_	_	_	_	_
38	was	be	_	_	_	_	_	_	_
39	required	require	_	_	_	_	_	_	_
40	for	for	_	_	_	_	_	_	_
41	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
42	activation	activation	_	_	_	_	_	_	_
43	in	in	_	_	_	_	_	_	_
44	these	these	_	_	_	_	_	_	_
45	cells	cell	_	_	_	_	_	_	_
46	.	.	_	_	_	_	_	_	_

1	IL-1beta	IL-1beta	_	_	_	_	_	_	_
2	stimulation	stimulation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	epithelial	epithelial	_	_	_	_	_	_	_
5	cells	cell	_	_	_	_	_	_	_
6	did	do	_	_	_	_	_	_	_
7	not	not	_	_	_	_	_	_	_
8	generate	generate	_	_	_	_	_	_	_
9	any	any	_	_	_	_	_	_	_
10	ROIs	ROI	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
13	induction	induction	_	_	_	_	_	_	_
14	was	be	_	_	_	_	_	_	_
15	not	not	_	_	_	_	_	_	_
16	influenced	influence	_	_	_	_	_	_	_
17	by	by	_	_	_	_	_	_	_
18	5-LOX	5-lox	_	_	_	_	_	_	_
19	inhibitors	inhibitor	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	reintroduction	reintroduction	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	functional	functional	_	_	_	_	_	_	_
7	5-LOX	5-lox	_	_	_	_	_	_	_
8	system	system	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	these	these	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	allowed	allow	_	_	_	_	_	_	_
13	ROI	ROI	_	_	_	_	_	_	_
14	production	production	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	5-LOX-dependent	5-lox-dependent	_	_	_	_	_	_	_
17	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
18	activation	activation	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	monocytic	monocytic	_	_	_	_	_	_	_
3	cells	cell	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	IL-1beta	IL-1beta	_	_	_	_	_	_	_
6	treatment	treatment	_	_	_	_	_	_	_
7	led	lead	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	production	production	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	ROIs	ROI	_	_	_	_	_	_	_
13	which	which	_	_	_	_	_	_	_
14	is	be	_	_	_	_	_	_	_
15	independent	independent	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	5-LOX	5-lox	_	_	_	_	_	_	_
19	enzyme	enzyme	_	_	_	_	_	_	_
20	but	but	_	_	_	_	_	_	_
21	requires	require	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	NADPH	NADPH	_	_	_	_	_	_	_
24	oxidase	oxidase	_	_	_	_	_	_	_
25	activity	activity	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	pathway	pathway	_	_	_	_	_	_	_
3	involves	involve	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	Rac1	rac1	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	Cdc42	cdc42	_	_	_	_	_	_	_
8	GTPases	gtpas	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	two	two	_	_	_	_	_	_	_
11	enzymes	enzyme	_	_	_	_	_	_	_
12	which	which	_	_	_	_	_	_	_
13	are	be	_	_	_	_	_	_	_
14	not	not	_	_	_	_	_	_	_
15	required	require	_	_	_	_	_	_	_
16	for	for	_	_	_	_	_	_	_
17	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
18	activation	activation	_	_	_	_	_	_	_
19	by	by	_	_	_	_	_	_	_
20	IL-1beta	IL-1beta	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	epithelial	epithelial	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	conclusion	conclusion	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	three	three	_	_	_	_	_	_	_
5	different	different	_	_	_	_	_	_	_
6	cell-specific	cell-specific	_	_	_	_	_	_	_
7	pathways	pathway	_	_	_	_	_	_	_
8	lead	lead	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
11	activation	activation	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	IL-1beta	IL-1beta	_	_	_	_	_	_	_
14	:	:	_	_	_	_	_	_	_
15	a	a	_	_	_	_	_	_	_
16	pathway	pathway	_	_	_	_	_	_	_
17	dependent	dependent	_	_	_	_	_	_	_
18	on	on	_	_	_	_	_	_	_
19	ROI	ROI	_	_	_	_	_	_	_
20	production	production	_	_	_	_	_	_	_
21	by	by	_	_	_	_	_	_	_
22	5-LOX	5-lox	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	lymphoid	lymphoid	_	_	_	_	_	_	_
25	cells	cell	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	an	an	_	_	_	_	_	_	_
28	ROI-	ROI-	_	_	_	_	_	_	_
29	and	and	_	_	_	_	_	_	_
30	5-LOX-independent	5-lox-independent	_	_	_	_	_	_	_
31	pathway	pathway	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	epithelial	epithelial	_	_	_	_	_	_	_
34	cells	cell	_	_	_	_	_	_	_
35	,	,	_	_	_	_	_	_	_
36	and	and	_	_	_	_	_	_	_
37	a	a	_	_	_	_	_	_	_
38	pathway	pathway	_	_	_	_	_	_	_
39	requiring	require	_	_	_	_	_	_	_
40	ROI	ROI	_	_	_	_	_	_	_
41	production	production	_	_	_	_	_	_	_
42	by	by	_	_	_	_	_	_	_
43	NADPH	NADPH	_	_	_	_	_	_	_
44	oxidase	oxidase	_	_	_	_	_	_	_
45	in	in	_	_	_	_	_	_	_
46	monocytic	monocytic	_	_	_	_	_	_	_
47	cells	cell	_	_	_	_	_	_	_
48	.	.	_	_	_	_	_	_	_

